THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD ONE (1) OF THE CONTRACT. THE GOVERNMENT HEREB…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- W81K0224P0059
- Contractor
- ROCHE DIAGNOSTICS CORPORATION
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Army
- Award amount
- $297,477
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- PSC 6550
- Place of performance
- INDIANAPOLIS, IN, 462561025, USA
- Competition
- FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 3 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $297,477 · Obligated $148,739 · Potential value $743,693 · Latest action obligation $0
Public award description
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD ONE (1) OF THE CONTRACT. THE GOVERNMENT HEREBY EXERCISES OPTION PERIOD ONE UNDER THE CONTRACT FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.